Cdk2/Cdc2 Polyclonal Antibody

CDK2 encodes a member of a family of serine/threonine protein kinases that participate in cell cycle regulation. Cyclin dependent kinase 2 is the catalytic subunit of the cyclin-dependent protein kinase complex, which regulates progression through the cell cycle. Activity of this protein is especially critical during the G1 to S phase transition. This protein associates with and regulated by other subunits of the complex including cyclin A or E, CDK inhibitor p21Cip1 (CDKN1A), and p27Kip1 (CDKN1B). Alternative splicing results in multiple transcript variants.

The Cdk2/Cdc2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of Cdk2 and Cdc2 proteins. This antibody is produced through a rigorous process, ensuring its high affinity and specificity towards the target proteins.

Cdk2 and Cdc2 are key regulators of the cell cycle, playing crucial roles in cell division and proliferation. The Cdk2/Cdc2 Polyclonal Antibody recognizes and binds to these proteins, allowing for their precise localization and quantification in various biological samples.

This antibody exhibits exceptional sensitivity and selectivity, enabling accurate and reproducible results in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. Its versatility makes it an invaluable tool for researchers studying cell cycle regulation, cancer biology, and other related fields.

The Cdk2/Cdc2 Polyclonal Antibody is manufactured using high-quality materials and state-of-the-art techniques, ensuring its superior performance and reliability. It has been extensively validated and proven to deliver consistent and robust results across different experimental conditions.

With its exceptional specificity, sensitivity, and reliability, the Cdk2/Cdc2 Polyclonal Antibody is an indispensable tool for researchers seeking to unravel the intricate mechanisms underlying cell cycle control and its implications in various biological processes.